CircRAD23B promotes proliferation and carboplatin resistance in ovarian cancer cell lines and organoids

Table 1 The relationship between carboplatin resistance and clinicopathologic features of patients with OC

Characteristics	Resistant	Sensitive	P value
n	42	34
Age, mean ± SD	58.905 ± 7.0635	59.941 ± 5.5919	0.488
circRAD23B expression, median (IQR)	0.055635 (0.031743, 0.068631)	0.034036 (0.010424, 0.050689)	0.008
Stage, n (%)			0.659
Stage2	5 (6.6%)	2 (2.6%)
Stage3	26 (34.2%)	22 (28.9%)
Stage4	11 (14.5%)	10 (13.2%)
Patients’ weight, median (IQR)(Kg)	51 (47, 62)	56.5 (52.25, 63.5)	0.136

ISSN: 1475-2867